Racial disparities in the receipt of adjuvant chemotherapy in patients with resected stage I-III pancreatic adenocarcinoma.

被引：0
|
作者：
Sanford, Nina Niu
Xu, Xiaohan
Sher, David J.
机构：
[1] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
[2] UT Southwestern, Dallas, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 04期
关键词：
D O I：
10.1200/JCO.2019.37.4_suppl.357
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
357
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Sociodemographic Disparities in the Receipt of Adjuvant Chemotherapy Among Patients With Resected Stage I-III Pancreatic Adenocarcinoma
    Sanford, Nina N.
    Aguilera, Todd A.
    Folkert, Michael R.
    Ahn, Chul
    Mahal, Brandon A.
    Zeh, Herbert
    Beg, Muhammad S.
    Mansour, John
    Sher, David J.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (11): : 1292 - +
  • [2] Preliminary Analysis of Adjuvant Chemotherapy with Atezolizumab in Stage I-III Resected NSCLC and Clearance of ctDNA
    Maniar, R.
    Shum, E.
    Mohindra, N. A.
    Owen, D. H.
    Ma, P. C.
    Haigentz, M., Jr.
    Hall, R. D.
    Rajguru, S. A.
    Grindheim, J.
    Schulze, K.
    Hanna, N. H.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S117 - S118
  • [3] Survival impact of adjuvant chemotherapy for resected early-stage rectal adenocarcinoma.
    Tay, Rebecca Yin
    Jamnagerwalla, Murtaza
    Steel, Malcolm
    Wong, Hui-Li
    McKendrick, Joseph James
    Faragher, Ian
    Kosmider, Suzanne
    Hastie, Ian
    Desai, Jayesh
    Gibbs, Peter
    Wong, Rachel
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [4] Racial and elderly disparities in receipt of guideline-concordant care in stage I-III breast cancer.
    Castillo, Brenda Sofia
    Boadi, Taussia
    Han, Xiaoyan
    Shulman, Lawrence N.
    Martei, Yehoda M.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [5] RACIAL DISPARITIES IN SHORT-TERM ONCOLOGICAL OUTCOMES IN STAGE I-III RESECTED RECTAL CANCER.
    Morton, M. B.
    Zerhouni, Y.
    Fields, A. C.
    Goldberg, J.
    Irani, J.
    Bleday, R.
    Melnitchouk, N.
    DISEASES OF THE COLON & RECTUM, 2018, 61 (05) : E263 - E263
  • [6] Disparities in the Use of Chemotherapy in Patients with Resected Pancreatic Ductal Adenocarcinoma
    Michael J. Wright
    Heidi N. Overton
    Jonathan A. Teinor
    Ding Ding
    Richard A. Burkhart
    John L. Cameron
    Jin He
    Christopher L. Wolfgang
    Matthew J. Weiss
    Ammar A. Javed
    Journal of Gastrointestinal Surgery, 2020, 24 : 1590 - 1596
  • [7] Disparities in the Use of Chemotherapy in Patients with Resected Pancreatic Ductal Adenocarcinoma
    Wright, Michael J.
    Overton, Heidi N.
    Teinor, Jonathan A.
    Ding, Ding
    Burkhart, Richard A.
    Cameron, John L.
    He, Jin
    Wolfgang, Christopher L.
    Weiss, Matthew J.
    Javed, Ammar A.
    JOURNAL OF GASTROINTESTINAL SURGERY, 2020, 24 (07) : 1590 - 1596
  • [8] Racial Disparities in the Outcomes of Patients With Stage IV Pancreatic Adenocarcinoma Are Mediated by Chemotherapy Utilization
    Atkins, Jordan J.
    Fiala, Mark A.
    Wang-Gillam, Andrea
    Wildes, Tanya M.
    PANCREAS, 2016, 45 (07) : E33 - E34
  • [9] Real-world impact of initial treatment modality on survival outcomes in patients with stage I-III pancreatic ductal adenocarcinoma.
    Prakash, Ajay
    Schwanke, Joschua
    Thuy-Hong Le-Kumar
    Patterson, Brooke
    Marmor, Schelomo
    Tignanelli, Christopher
    Jensen, Eric Hans
    Lou, Emil
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 684 - 684
  • [10] Adjuvant docetaxel and carboplatin chemotherapy for patients with FIGO stage I-III endometrial cancer
    Kudaka, W.
    Nakasone, T.
    Arakaki, Y.
    Nakamoto, T.
    Wakayama, A.
    Kinjyo, Y.
    Taira, Y.
    Nagai, Y.
    Kaneshima, I.
    Nishihira, K.
    Aoki, Y.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 1011 - 1011
12345